| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | CCR6 chemokine receptor binding | 7.80e-07 | 13 | 29 | 3 | GO:0031731 | |
| GeneOntologyMolecularFunction | chemoattractant activity | 6.50e-05 | 54 | 29 | 3 | GO:0042056 | |
| GeneOntologyMolecularFunction | CCR chemokine receptor binding | 7.25e-05 | 56 | 29 | 3 | GO:0048020 | |
| GeneOntologyMolecularFunction | histone H3K36 demethylase activity | 1.11e-04 | 11 | 29 | 2 | GO:0051864 | |
| GeneOntologyMolecularFunction | chemokine receptor binding | 2.18e-04 | 81 | 29 | 3 | GO:0042379 | |
| GeneOntologyMolecularFunction | histone H3 demethylase activity | 7.52e-04 | 28 | 29 | 2 | GO:0141052 | |
| GeneOntologyMolecularFunction | histone demethylase activity | 9.23e-04 | 31 | 29 | 2 | GO:0032452 | |
| GeneOntologyMolecularFunction | protein demethylase activity | 9.83e-04 | 32 | 29 | 2 | GO:0140457 | |
| GeneOntologyMolecularFunction | cytokine receptor binding | 1.17e-03 | 324 | 29 | 4 | GO:0005126 | |
| GeneOntologyMolecularFunction | demethylase activity | 1.86e-03 | 44 | 29 | 2 | GO:0032451 | |
| Domain | CAMSAP_CH | 4.53e-05 | 7 | 28 | 2 | PF11971 | |
| Domain | CAMSAP_CH | 4.53e-05 | 7 | 28 | 2 | IPR022613 | |
| Domain | Defensin_beta | 1.42e-04 | 12 | 28 | 2 | PF00711 | |
| Domain | Defensin_beta-typ | 1.42e-04 | 12 | 28 | 2 | IPR001855 | |
| Domain | JmjC | 5.86e-04 | 24 | 28 | 2 | PF02373 | |
| Domain | JMJC | 1.05e-03 | 32 | 28 | 2 | PS51184 | |
| Domain | JmjC_dom | 1.05e-03 | 32 | 28 | 2 | IPR003347 | |
| Domain | JmjC | 1.11e-03 | 33 | 28 | 2 | SM00558 | |
| Domain | Znf_FYVE_PHD | 1.35e-03 | 147 | 28 | 3 | IPR011011 | |
| Domain | Channel_four-helix_dom | 3.29e-03 | 57 | 28 | 2 | IPR027359 | |
| Domain | - | 3.29e-03 | 57 | 28 | 2 | 1.20.120.350 | |
| Domain | CH | 4.25e-03 | 65 | 28 | 2 | SM00033 | |
| Domain | CH | 4.91e-03 | 70 | 28 | 2 | PF00307 | |
| Domain | IQ | 5.05e-03 | 71 | 28 | 2 | PF00612 | |
| Domain | - | 5.05e-03 | 71 | 28 | 2 | 1.10.418.10 | |
| Domain | CH | 5.33e-03 | 73 | 28 | 2 | PS50021 | |
| Domain | CH-domain | 5.62e-03 | 75 | 28 | 2 | IPR001715 | |
| Domain | IQ | 6.53e-03 | 81 | 28 | 2 | SM00015 | |
| Domain | PHD | 7.83e-03 | 89 | 28 | 2 | SM00249 | |
| Domain | IQ_motif_EF-hand-BS | 8.00e-03 | 90 | 28 | 2 | IPR000048 | |
| Domain | Znf_PHD | 8.17e-03 | 91 | 28 | 2 | IPR001965 | |
| Domain | IQ | 8.52e-03 | 93 | 28 | 2 | PS50096 | |
| Domain | ZF_PHD_2 | 8.88e-03 | 95 | 28 | 2 | PS50016 | |
| Domain | ZF_PHD_1 | 9.06e-03 | 96 | 28 | 2 | PS01359 | |
| Pathway | REACTOME_BETA_DEFENSINS | 3.91e-05 | 43 | 22 | 3 | M565 | |
| Pathway | REACTOME_DEFENSINS | 7.35e-05 | 53 | 22 | 3 | M557 | |
| Pathway | REACTOME_BETA_DEFENSINS | 4.34e-04 | 20 | 22 | 2 | MM14567 | |
| Pathway | REACTOME_ANTIMICROBIAL_PEPTIDES | 4.56e-04 | 98 | 22 | 3 | M27627 | |
| Pathway | REACTOME_HDMS_DEMETHYLATE_HISTONES | 9.20e-04 | 29 | 22 | 2 | MM14934 | |
| Pathway | REACTOME_DEFENSINS | 1.05e-03 | 31 | 22 | 2 | MM14568 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 14625278 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 28181499 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 27261276 | ||
| Pubmed | 3.35e-06 | 35 | 29 | 3 | 16033865 | ||
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 36631800 | ||
| Pubmed | CD300 molecule regulation of human dendritic cell functions. | 4.02e-06 | 4 | 29 | 2 | 23072861 | |
| Pubmed | 6.70e-06 | 5 | 29 | 2 | 22291008 | ||
| Pubmed | 1.00e-05 | 6 | 29 | 2 | 29051512 | ||
| Pubmed | CD300 heterocomplexes, a new and family-restricted mechanism for myeloid cell signaling regulation. | 1.00e-05 | 6 | 29 | 2 | 20959446 | |
| Pubmed | The CD300 family of molecules are evolutionarily significant regulators of leukocyte functions. | 1.41e-05 | 7 | 29 | 2 | 19359216 | |
| Pubmed | The CD300 molecules regulate monocyte and dendritic cell functions. | 1.41e-05 | 7 | 29 | 2 | 19592130 | |
| Pubmed | Long non-coding RNA LncKdm2b regulates cortical neuronal differentiation by cis-activating Kdm2b. | 3.68e-05 | 11 | 29 | 2 | 31317506 | |
| Pubmed | CMRF-35-like molecule-1, a novel mouse myeloid receptor, can inhibit osteoclast formation. | 5.21e-05 | 13 | 29 | 2 | 14662855 | |
| Pubmed | 1.14e-04 | 19 | 29 | 2 | 19148283 | ||
| Pubmed | 1.26e-04 | 20 | 29 | 2 | 37073980 | ||
| Pubmed | Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition. | 1.40e-04 | 21 | 29 | 2 | 27626377 | |
| Pubmed | 1.50e-04 | 326 | 29 | 4 | 17015433 | ||
| Pubmed | Manual annotation and analysis of the defensin gene cluster in the C57BL/6J mouse reference genome. | 1.99e-04 | 25 | 29 | 2 | 20003482 | |
| Pubmed | 2.69e-04 | 29 | 29 | 2 | 20972250 | ||
| Pubmed | 2.69e-04 | 29 | 29 | 2 | 20167577 | ||
| Pubmed | The Trim family of genes and the retina: Expression and functional characterization. | 3.49e-04 | 33 | 29 | 2 | 30208054 | |
| Pubmed | Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM. | 3.49e-04 | 33 | 29 | 2 | 26864203 | |
| Pubmed | 3.49e-04 | 33 | 29 | 2 | 18193044 | ||
| Pubmed | Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. | 3.70e-04 | 34 | 29 | 2 | 19060911 | |
| Pubmed | Newly identified loci that influence lipid concentrations and risk of coronary artery disease. | 3.93e-04 | 35 | 29 | 2 | 18193043 | |
| Pubmed | Genome-wide association study identifies multiple loci influencing human serum metabolite levels. | 6.79e-04 | 46 | 29 | 2 | 22286219 | |
| Pubmed | Genetic variants influencing circulating lipid levels and risk of coronary artery disease. | 7.71e-04 | 49 | 29 | 2 | 20864672 | |
| Pubmed | 7.71e-04 | 49 | 29 | 2 | 34368113 | ||
| Cytoband | 8p23.1 | 1.27e-04 | 154 | 29 | 3 | 8p23.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | 4.33e-04 | 234 | 29 | 3 | chr8p23 | |
| Cytoband | 17q25.1 | 1.21e-03 | 81 | 29 | 2 | 17q25.1 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 4.20e-04 | 24 | 23 | 2 | 485 | |
| GeneFamily | Defensins, beta | 1.62e-03 | 47 | 23 | 2 | 503 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Rectal_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 9.32e-05 | 136 | 29 | 3 | feb957df4bff3266cb9a7382b16fc927ae03b9b4 | |
| ToppCell | mild_COVID-19_(asymptomatic)-Treg|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.13e-04 | 145 | 29 | 3 | 2d0903009e918500facfd017ff31f2cec1e76131 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_ALM_Tgfb1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.13e-04 | 145 | 29 | 3 | 84d50a13b48d50c16e768422908e371a55972d0e | |
| ToppCell | normal_Lung-Endothelial_cells-Tumor_ECs|Endothelial_cells / Location, Cell class and cell subclass | 1.35e-04 | 154 | 29 | 3 | afdc385397c7b13c9348eeef95f109f2363057ae | |
| ToppCell | facs-Spleen-nan-3m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 156 | 29 | 3 | f532ef4e92ac7661b1a8a4f2e98d80ce8d4e3655 | |
| ToppCell | facs-Spleen-nan-3m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 156 | 29 | 3 | da4f35353a84d919e683554932f110e29568df33 | |
| ToppCell | facs-Spleen-nan-3m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 156 | 29 | 3 | f1e25ff85c5f2f8555f9fb5ae5daed7ddb418fd1 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Myeloid-mast_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-04 | 157 | 29 | 3 | cca7f23485b9d1a1c96134b6ca85dc7dba0c0522 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-04 | 157 | 29 | 3 | 241c983fc3fc5c98113baf27e03ff0eede611bd8 | |
| ToppCell | Frontal_cortex-Hematopoietic-MICROGLIA|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.48e-04 | 159 | 29 | 3 | 41d2c1e71f6983156f8cc8ec5f69e025e5700f46 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 160 | 29 | 3 | 97c899df1b57fd2bd1867e02bfedf1920c00ad17 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 164 | 29 | 3 | 07d9252b267cb61c6050fbfa5b440aef1349f673 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 164 | 29 | 3 | 7c016236f0cea38195c1373ebbd2c0b2b2ec81ad | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-04 | 166 | 29 | 3 | fab4da2537904ad114218f720e18a600f14a00a1 | |
| ToppCell | Bronchial_Biopsy-Immune-T_and_NK|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.74e-04 | 168 | 29 | 3 | 435b2f238fbb3f50427e8cdecf2220615015153c | |
| ToppCell | Endothelial-B-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 1.74e-04 | 168 | 29 | 3 | 4977c3837fbb1f36c89fddd5764e37290ac25ad8 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.80e-04 | 170 | 29 | 3 | 7534ac69ca3a378df78d61c284e89bc96a71a4a8 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 171 | 29 | 3 | ab21f20ec041cbaacccbd7da4dccdb77ec8bc5c6 | |
| ToppCell | Endothelial-B-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.83e-04 | 171 | 29 | 3 | 07ff7059071da83da1d8f266a586573920d75b58 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 171 | 29 | 3 | 97ad2cfff568a9d006ab1d2e6e00946ee4e3beb3 | |
| ToppCell | Endothelial-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 1.86e-04 | 172 | 29 | 3 | 8a527dff06d841a86c7eb04a1dd9630787294da4 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 173 | 29 | 3 | 0f9784b30c81a4a4940e0623cec60d596e9985d2 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 173 | 29 | 3 | a5172dee859bf6c2eed46c48bd64dfef0ff9f28f | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 173 | 29 | 3 | 639b5b0b33ce5aa0bc26363c059717012ddc14c0 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 173 | 29 | 3 | 60f79e0698a7cf7516690fb20f1b82ee46547699 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-04 | 181 | 29 | 3 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.20e-04 | 182 | 29 | 3 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.20e-04 | 182 | 29 | 3 | 53c267ee327e116dbd89d5927ed3bdf78d25ee62 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.35e-04 | 186 | 29 | 3 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.38e-04 | 187 | 29 | 3 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | Tuft-tuft-2|World / Class top | 2.38e-04 | 187 | 29 | 3 | 4ec6eee866619dfe13c84f5d2e812bb380d37139 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.54e-04 | 191 | 29 | 3 | 54f07e4de61735051498846afb44b1798bed8144 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.58e-04 | 192 | 29 | 3 | 0003d7ef9a8e521e70ac33c63aad843d9b6215c2 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.62e-04 | 193 | 29 | 3 | 7cd9671e0ac64f7f3607f564485c63abbb7e7a63 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.62e-04 | 193 | 29 | 3 | bd0027fa97de41ae22ff64a61c8e217496f122ca | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.62e-04 | 193 | 29 | 3 | c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9 | |
| ToppCell | (07)_Brush|World / shred by cell type and Timepoint | 2.62e-04 | 193 | 29 | 3 | 9af9d22a130ff97a9c37142a65e841b056d08640 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.62e-04 | 193 | 29 | 3 | 5581a5ebcd21a2a8062ccfb917f088ec67a10a9c | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.90e-04 | 200 | 29 | 3 | 4a426ef88376d8bb2b9dc50aa06e7b9fc50ecc9c | |
| ToppCell | Biopsy_Control_(H.)-Endothelial-Lymphatic_Endothelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.90e-04 | 200 | 29 | 3 | 8cf218887ab030b7625610cb65b595170a17ebec | |
| ToppCell | Transverse-(3)_ILC-(30)_ILC|Transverse / shred on region, Cell_type, and subtype | 2.90e-04 | 200 | 29 | 3 | 528520dc98775aca6cc7568fedf5906ea55e0bea | |
| ToppCell | Transverse-(3)_ILC|Transverse / shred on region, Cell_type, and subtype | 2.90e-04 | 200 | 29 | 3 | c1ad7cb012e1c8911e417f7d64ca662c4f5010e0 | |
| ToppCell | Sigmoid-(1)_T_cell-(18)_cycling_gd_T|Sigmoid / shred on region, Cell_type, and subtype | 2.90e-04 | 200 | 29 | 3 | 6e367abd1a4b87e20eb9095b8337723163e8bbae | |
| ToppCell | Transverse-ILC|Transverse / Region, Cell class and subclass | 2.90e-04 | 200 | 29 | 3 | eb04d6ad2270d3d9ac3d1fae1bb9bedc6fca38fe | |
| ToppCell | Transverse-ILC-ILC|Transverse / Region, Cell class and subclass | 2.90e-04 | 200 | 29 | 3 | 60ec185df2f1989bf8febf75b11c46a576829be3 | |
| ToppCell | mLN-Dendritic_cell-Lymphoid_DC|Dendritic_cell / Region, Cell class and subclass | 2.90e-04 | 200 | 29 | 3 | 3813fa1ee1462ba83fd8b6253070f46f0b063084 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.90e-04 | 200 | 29 | 3 | fbeee1c16ac0a7fe28d90491c8b079f21ce80bdc | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.90e-04 | 200 | 29 | 3 | c6eda342ea0cb37d71d89dbb8d11e819e0745172 | |
| ToppCell | Sigmoid-T_cell-cycling_gd_T|Sigmoid / Region, Cell class and subclass | 2.90e-04 | 200 | 29 | 3 | 9769185abae084ffac36420c749625e679b70ca8 | |
| Disease | phosphatidylcholine measurement | 1.24e-04 | 284 | 27 | 4 | EFO_0010226 | |
| Disease | obsolete_red blood cell distribution width | 1.61e-04 | 1347 | 27 | 7 | EFO_0005192 | |
| Disease | free cholesterol in small HDL measurement | 4.71e-04 | 35 | 27 | 2 | EFO_0022270 | |
| Disease | total lipids in small HDL measurement | 4.71e-04 | 35 | 27 | 2 | EFO_0022311 | |
| Disease | cholesteryl esters to total lipids in medium LDL percentage | 5.26e-04 | 37 | 27 | 2 | EFO_0022252 | |
| Disease | phospholipids in small HDL measurement | 5.55e-04 | 38 | 27 | 2 | EFO_0022296 | |
| Disease | C-reactive protein measurement | 6.51e-04 | 1206 | 27 | 6 | EFO_0004458 | |
| Disease | cholesteryl esters to total lipids in small LDL percentage | 6.79e-04 | 42 | 27 | 2 | EFO_0022255 | |
| Disease | cholesteryl esters to total lipids in small HDL percentage | 7.11e-04 | 43 | 27 | 2 | EFO_0022254 | |
| Disease | saturated fatty acids measurement | 7.79e-04 | 45 | 27 | 2 | EFO_0022304 | |
| Disease | phosphoglycerides measurement | 8.86e-04 | 48 | 27 | 2 | EFO_0022291 | |
| Disease | total lipids in lipoprotein particles measurement | 8.86e-04 | 48 | 27 | 2 | EFO_0022309 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 9.61e-04 | 50 | 27 | 2 | EFO_0022247 | |
| Disease | cholesterol to total lipids in small HDL percentage | 1.00e-03 | 51 | 27 | 2 | EFO_0022240 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.08e-03 | 222 | 27 | 3 | EFO_0008317, EFO_0020943 | |
| Disease | triglycerides in HDL measurement | 1.08e-03 | 53 | 27 | 2 | EFO_0022317 | |
| Disease | triglycerides in medium HDL measurement | 1.12e-03 | 54 | 27 | 2 | EFO_0022321 | |
| Disease | IGFBP-3 measurement | 1.12e-03 | 54 | 27 | 2 | EFO_0004626 | |
| Disease | triglycerides in very large HDL measurement | 1.16e-03 | 55 | 27 | 2 | EFO_0022324 | |
| Disease | cholesterol in IDL measurement | 1.29e-03 | 58 | 27 | 2 | EFO_0021899 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.33e-03 | 239 | 27 | 3 | EFO_0008317, EFO_0020945 | |
| Disease | phospholipids in very large HDL measurement | 1.67e-03 | 66 | 27 | 2 | EFO_0022298 | |
| Disease | total lipids in very large HDL measurement | 1.67e-03 | 66 | 27 | 2 | EFO_0022312 | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 1.72e-03 | 67 | 27 | 2 | EFO_0008595, EFO_0020946 | |
| Disease | phospholipids in large HDL measurement | 2.04e-03 | 73 | 27 | 2 | EFO_0022190 | |
| Disease | total lipids in large HDL | 2.09e-03 | 74 | 27 | 2 | EFO_0022189 | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 2.32e-03 | 78 | 27 | 2 | EFO_0022187 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.33e-03 | 291 | 27 | 3 | EFO_0008317, EFO_0020946 | |
| Disease | free cholesterol in large HDL measurement | 2.38e-03 | 79 | 27 | 2 | EFO_0022157 | |
| Disease | cholesterol in large HDL measurement | 2.44e-03 | 80 | 27 | 2 | EFO_0021900 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RAQCVGWHSKKRRWD | 346 | Q8IZF3 | |
| RLKRIWNWRACEAAK | 251 | O60563 | |
| RGVDANRNWKVKWCD | 266 | Q8N4T0 | |
| KAACKIQAWYRCWRA | 2956 | Q8IZT6 | |
| TVVCWVWICRKRKRE | 251 | Q6UX15 | |
| WLCARCKRNAWTAEC | 741 | Q9H3R0 | |
| RELWFRKCRDGWRMK | 476 | Q9Y5X9 | |
| EWQVASRRRKAWAKC | 16 | P28290 | |
| GICNEGKKCCRRWWI | 51 | P0DP73 | |
| MRVCRTWNRWCCDKR | 1086 | Q8NHM5 | |
| KWWCRGAIWRDCKIL | 51 | Q8TDQ1 | |
| GACRRRMKCCRAWWI | 51 | Q30KR1 | |
| KCRAPAWCDRILWKG | 596 | P32019 | |
| GICNEGKKCCRRWWI | 51 | P0DP74 | |
| VCKRLCTERQKSWWD | 511 | P0DJD0 | |
| WLCKICSEQREVWKR | 136 | Q9UNE2 | |
| QGRGKKWWTLRRACF | 1011 | P35499 | |
| CRDKIRLNNAIWRAW | 116 | Q9NP71 | |
| QGWKERWCRLKCNTL | 431 | Q8TED9 | |
| IKWWCRGVRWDTCKI | 46 | A8K4G0 | |
| CHCWEDIWRVNIQRK | 76 | Q6ZN11 | |
| LWCTACRWKKACQRF | 371 | Q9NR83 | |
| LGRWWRIKEARNSVC | 446 | O43818 | |
| WTCDCRLRGLKRWMG | 361 | Q7L0X0 | |
| GIEHRDQWCTACRWK | 491 | Q9H8N7 | |
| DQWCTACRWKKACQR | 496 | Q9H8N7 | |
| WSACNVRCGRGWQKR | 261 | Q6UXZ4 | |
| MEQWRQCGRWLIDCK | 1 | P52735 | |
| AKWRKREKCWGRSSV | 201 | P58304 | |
| AAEGRWRRCQKCVWK | 156 | Q9H3M0 |